Drugs Targeting B-Cells in Autoimmune Diseases
This book provides a detailed overview of B-cell directed therapies in patients with rheumatic and systemic autoimmune diseases, including rheumatoid arthritis, systemic lupus erythematosus, Sjögren syndrome, ANCA-associated vasculitis and cryoglobulinemia. Organ-specific autoimmune diseases are dis...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Basel :
Springer Basel : Imprint: Springer,
2014.
|
Σειρά: | Milestones in Drug Therapy,
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Historic outline of the development of drugs targeting B-cells
- Understanding B-cell biology
- Pharmacological effects and mechanisms of action of agents blocking B cells
- Systemic lupus erythematosus: direct B-cell blocking
- Systemic lupus erythematosus: indirect B-cell blocking
- B-cell targeted therapies in rheumatoid arthritis
- B-cell targeted therapies in Primary Sjögren Syndrome
- Targeting B cells in ANCA-associated vasculitis
- B-cell targeted therapies in systemic sclerosis and inflammatory myopathies
- B-cell targeted therapies in cryoglobulinemia
- B-cell targeted therapies in autoimmune cytopenias and thrombosis
- Targeting B cells in neurological autoimmune diseases
- Targeting B cells in other systemic autoimmune diseases
- Safety of B-cell targeted therapies
- The future potential of biosimilars targeting B-cells.